Related by context. All words. (Click for frequent words.) 71 stockholder approvals 70 shareholder approvals 65 disinterested shareholder 64 requisite stockholder 63 requisite regulatory approvals 62 unitholder approval 62 applicable regulatory approvals 61 warrantholders 60 customary closing 59 customary regulatory approvals 59 Proposed Transaction 59 customary closing conditions 59 regulatory approvals 59 regulatory clearances 58 requisite consents 58 necessary regulatory approvals 58 requisite approvals 58 stockholders 57 solicit proxies 57 securityholder approval 56 regulatory approval 56 Shareholder Approval 56 Merger Agreement 56 Requisite Consents 56 antitrust clearance 55 HSR clearance 55 Upon consummation 55 Stockholders 55 consummation 55 optionholders 55 Neurogen stockholders 55 governmental approvals 55 TechTeam Global stockholders 54 Lumera stockholders 54 consents authorizations 54 commonstock 54 shares issuable pursuant 54 Common Stock 54 lender consents 54 transactions contemplated 54 Restated Certificate 54 Business Combination 54 Stockholder Approval 53 Reverse Stock 53 B Preferred Stock 53 Definitive Proxy Statement 53 soliciting proxies 53 Recapitalization Agreement 53 stockholder 53 Equity Incentive Plan 53 regain compliance 53 Aeroflex stockholders 52 Xenith Corporation 52 definitive proxy statement 52 proxy statement 52 definitive documentation 52 execute supplemental indenture 52 Consummation 52 Merger Sub 52 Metabasis stockholders 52 Qualifying Transaction 52 LaSalle Closed End 52 Arrangement Agreement 51 NRDC Acquisition stockholders 51 Hart Scott Rodino 51 Acquisition Transaction 51 Warrantholders 51 On2 stockholders 51 Aurvista 51 issuable pursuant 51 Data Domain stockholders 51 soliciting consents 51 NASDAQ Listing 51 Comamtech 51 definitive Proxy Statement 51 IsoTis stockholders 51 Securities Purchase Agreement 50 AuthenTec stockholders 50 Hanlong transaction 50 Stock Purchase Agreement 50 Incentive Compensation Plan 50 Nasdaq Listing Qualifications 50 CommScope stockholders 50 Wintraysan 50 securityholders 50 Combination Transaction 50 Nasdaq SmallCap Market 50 Proposed Transactions 50 Rights Plan 50 NASDAQ Hearings Panel 50 GHL Acquisition stockholders 50 definitive proxy 50 BiDil XR drug 50 initiate delisting 50 Stockholders Approve 50 Combination Agreement 49 NASDAQ Listing Qualifications 49 Convertible Notes 49 Zila stockholders 49 Proposed Qualifying Transaction 49 reincorporation merger 49 Nasdaq Marketplace Rule 49 Terminates Merger Agreement 49 validly tendered Notes 49 Stockholders Meeting 49 CapGen Offering 49 vesting provisions 49 Refac 49 Share Consolidation 49 Arrangement 49 QMLP 49 Proxy Statement 49 Proposed Financing 49 Restated Articles 49 shares issuable 49 Cell Genesys stockholders 49 Staff Determination 49 Antitrust Improvements Act 49 NASDAQ Listing Rule 49 Reincorporation 49 Biomerge 49 definitive agreements 49 Rule #a 8 49 unvested options 49 issuable 49 Cellu Tissue stockholders 49 Files Shelf Registration Statement 49 Merger Transaction 49 Inducement Stock 49 securityholder 49 Discovery Informatics 49 Subscription Receipt 48 Nasdaq Hearings Panel 48 SMSC Transaction 48 Whitewash Waiver 48 Omnibus Incentive Plan 48 Conexant stockholders 48 shares issuable upon 48 Regains Compliance 48 Proposed Acquisition 48 NASDAQ Marketplace Rule 48 ArPetrol Transaction 48 Marketplace Rules 48 Listing Rule 48 Reverse Split 48 Amalgamation 48 Thoma Bravo Merger 48 NASDAQ Listing Rules 48 Nasdaq Listing Rule 48 Annual Stockholder Meeting 48 Preferred Stock 48 Receives NASDAQ 48 Superior Proposal 48 Wellco unitholders 48 Receives Stockholder Approval 48 warrantholder approval 48 stockholders Proxy Statement 48 Novacea stockholders 48 Vistior 48 Stockholder Rights Plan 48 Dynegy stockholders 48 Trubion stockholders 48 Inc. NASDAQ NETM 48 consummated 48 remaining untendered 48 Xenith Bankshares 48 Stock Incentive Plan 48 Shareholders Approve Plan 48 accelerated vesting 48 acquiror 48 convertible preferred 48 beneficially owning 48 Announce Shareholder Approval 48 Share Repurchase Plan 48 Nasdaq Listing Requirements 48 exemptive relief 48 Arrangement Resolution 47 Stockholders Approve Merger 47 Merger Agreement dated 47 Amends Terms 47 Debentures 47 rStar 47 Catalyst Semiconductor stockholders 47 Apex Bioventures 47 Proxy Statement dated 47 Stock Split 47 Existing Warrants 47 NRDC Acquisition 47 Cornerstone BioPharma Holdings 47 Harbinger Parties 47 PharmaBio 47 Announces Shareholder Approval 47 Nasdaq IRSN 47 Secured Convertible Debentures 47 convertible notes 47 private placement 47 adjournment thereof 47 Zareba shareholders 47 Tendering holders 47 Recapitalization Transaction 47 Reports Inducement Grants 47 minimally dilutive 47 proxy circular 47 Transaction 47 Preferred Stockholders 47 NASDAQ CHIP VeriChip 47 EPE unitholders 47 Settlement Hearing 47 Schedule #C 47 attaching thereto 47 convertible promissory notes 47 liquidating distributions 47 Form #c# 47 Tremisis II 47 Reschedules Annual Meeting 47 Securities Repurchase Program 47 Proposed Amendments 47 Amalco Shares 47 Convertible Preferred Stock 47 Proposed QT 47 OTCBB BTEM 47 Debentureholder 47 NASDAQ LBTYA NASDAQ LBTYB 47 Stockholder Meeting 47 Cease Trade Orders 47 USPoly 47 Affected Creditors 47 Advises Stockholders 47 Contingent Value Rights 47 % Convertible Subordinated 47 PDTI 47 Alyst 47 Regains NASDAQ 47 valid acceptances 47 Innovision Shareholders 47 Avigen stockholders 47 Reverse Takeover 47 Announces Adjournment 47 TechTeam Global 47 QT Financing 47 CNIH 47 EnerCare Solutions 47 Canetic Unitholders 47 Repurchase Program 47 Abe Shainberg Esq 47 Staff Determination Letter 47 eXegenics 47 Amalco 47 satisfactory due diligence 47 Merger Proposal 47 Sets Record Date 47 amalgamated corporation 47 Common Shares 47 DSL.net s 46 Rozetta Cell 46 representations warranties covenants 46 unexercised warrants 46 pro rata portion 46 AAMAC stockholders 46 Nasdaq SmallCap 46 oversubscription privilege 46 Information Circular 46 Stock Repurchase Plan 46 Financing Transactions 46 LOI contemplates 46 VaxGen stockholders 46 adjournments thereof 46 UNNF 46 redomestication 46 Inducement Warrants 46 unvested stock 46 delisting proceedings 46 repurchases 46 requisite Consents 46 Letter Agreement 46 DTLL 46 Long Term Incentive Plan 46 NASDAQ SmallCap 46 Conversion Date 46 MVPHS 46 ALICO Holdings 46 Acquisition Agreement 46 Oremex Gold 46 SynthRx 46 NASDAQ Listing Qualification 46 Amalgamation Agreement 46 Bonus Warrants 46 Cash Consideration 46 IntelliPharmaCeutics Ltd. 46 Second Amended 46 Inc. Nasdaq NHRX 46 AGA Medical stockholders 46 EP MedSystems shareholders 46 NitroMed stockholders 46 Proxy Forms 46 Subscription Agreement 46 CHLP 46 Adamis Pharmaceuticals Corporation 46 thereunder 46 exercisability 46 NetApp Data Domain 46 shares issuable thereunder 46 Consent Fees 46 AAMAC 46 Fronteer Offer 46 Effective Date 46 mutually satisfactory definitive 46 Willowstar 46 Announce Early Termination 46 Adastra shareholders 46 LSRI Holdings 46 Inc. AMEX OKN 46 fractional shares 46 BreitBurn GP LLC 46 Pending regulatory approvals 46 Definitive Consent Revocation Statement 46 definitive merger 46 ReAble Therapeutics Inc. 46 Complete Liquidation 46 Nio Metals 46 MergerSub 46 PAIVIS 46 non waivable 46 ZYPS 46 Optionholders 46 Repurchase Date 46 BCSB Bankcorp 46 HSR Act 46 secured convertible debentures 46 indentures pursuant 46 tendered pursuant 46 purchase warrants exercisable 46 convertible promissory note 46 FIRB approval 46 SumTotal stockholders 46 Acquisition Proposal 46 reincorporation 46 Acquiring Person 46 Share Option 46 MQ Associates 46 Continued Listing 46 GHL Acquisition 46 outstanding indebtedness 46 Private Placement 46 Eurogas International 46 TRUSTCASH 46 tender offer 45 ARPS redemptions 45 Changes Ticker Symbol 45 Sale Transaction 45 CLHI 45 Acknowledges Receipt 45 On4 Communications Inc. 45 Shares issuable 45 Securities Purchase Agreements 45 Debenture holders 45 Second Tranche 45 Recapitalization 45 Receives Anticipated 45 Regains Nasdaq 45 TYN 45 definitive agreement 45 Rights Offering 45 XLNT Veterinary Care 45 Financing Condition 45 transaction 45 Silvercorp Offer 45 Antitrust Improvement 45 NETM 45 Debenture Financing 45 Medicis Inamed 45 NASDAQ CPEX 45 Asset Purchase Agreement 45 Concurrent Financing 45 Proginet stockholders 45 Marketplace Rule 45 Perpetual PIERS 45 Completes Previously Announced 45 Proposed Merger 45 trading symbol GCKO 45 Proposed Arrangement 45 Schedules Investor 45 transactions contemplated thereunder 45 Performance Incentive Plan 45 Thermadyne shareholders 45 Announces Record Date 45 Securityholders 45 MCI shareowners 45 Preliminary Proxy Statement 45 Mr. Mihaylo 45 supplemental indenture 45 Minimum Bid Price 45 Announces Postponement 45 Joint Proxy Statement 45 confirmatory due diligence 45 mandatorily convertible preferred 45 Regains Compliance With 45 Standby Purchase Agreement 45 Joint Proxy Statement Prospectus 45 Reorganization Proposal 45 Statement Prospectus 45 Senior Secured Convertible Debentures 45 Employment Inducement Equity Incentive 45 Stockholders Vote 45 Amended Offer 45 Nasdaq ETWC 45 warrantholder 45 AMPS Risk 45 BIP Interests 45 X Ceptor 45 Equitex 45 CompAir acquisition 45 thetransaction 45 Scheme Document 45 Inc. NYSE MYL 45 Aumento 45 ADSs 45 Stockholders Approve Merger Agreement 45 Fundamental Change 45 Scheme Consideration 45 shareholders 45 Proposed Combination 45 irrevocable undertakings 45 Evaluate Strategic Alternatives 45 unissued shares 45 Commences Mailing 45 Extends Expiration 45 Graniz Loan 45 Pharmachem Revised Offer 45 Nasdaq Minimum Bid 45 Adopts Stockholder Rights 45 Investigational Device Exemption 45 HSR Waiting Period 45 Definitive Agreement 45 Securities andExchange Commission 45 Minimum Tender Condition 45 voluntarily delist 45 iBasis stockholders 45 Corp. Nasdaq TLCR 45 Announces Stockholder Approval 45 Supplemental Indentures 45 Nasdaq BFRM 45 BPW Acquisition Corp. 45 AOLS Holdings 45 share repurchase authorizations 45 Reverse Merger 45 Acquisition 45 Initial Purchasers 45 Revised Offer 45 golden parachute arrangements 45 Purchase Warrants 45 PharMerica LTC Transaction 45 Certara Corporation 45 Vector Intersect 45 Listings Qualifications Panel 45 Hexion Proposal 45 Investigates Proposed Acquisition 45 Explores Strategic Alternatives 45 Schedule #A 45 NASDAQ EPMD 45 earnout payments 45 mutually acceptable definitive 45 Amended Plan 45 accompanying prospectus relating 45 Endocare stockholders 45 stockholders definitive proxy 45 Nasdaq ANIK 45 Tolmar 45 Seriatim 45 Brokered Financing 45 convertible subordinated notes 45 #,#,# warrants exercisable 45 beneficially owned approximately 45 delisting determination 45 Basic Subscription Privilege 45 ePresence 45 Value Creation Plan 45 Noteholder 45 Hurasu Resource Corporation 45 prepackaged bankruptcy proceeding 45 Proxy Statements 45 AMEX ISV 45 Trintech Shareholders 44 Cortelco 44 Microtune stockholders 44 exemptive order 44 Proxy Proposals 44 Registration Statement 44 Board Unanimously Rejects 44 Nasdaq HRLY 44 cusip number 44 Capital Reorganisation 44 Consummates 44 IPN Shareholders 44 Consent Letter 44 Pursuant 44 Solfotara 44 CF Industries stockholders 44 Corporation OTCBB SVUL 44 AAMAC warrantholders 44 Disinterested shareholders 44 dilutive issuances 44 Ideation Acquisition Corp. 44 Granahan McCourt 44 DGCL 44 NASDAQ Global 44 GBPO 44 issuable upon exercise 44 delisting 44 refinance indebtedness 44 Long Term Incentive Compensation 44 Osteotech stockholders 44 Unsolicited Proposal From 44 MRL Offers 44 NASDAQ INTL 44 Revised Proposal 44 Announces Effective Date 44 consummating acquisitions 44 Inc. NASDAQ CVTX 44 CreXus 44 Registration Statement Declared Effective 44 Alyst Acquisition Corp. 44 Issuer Bid 44 Asset Sale 44 OTCBB CPEU 44 Proposal contemplates 44 Shareholders 44 novel MetAP 2 44 Investus 44 consents 44 promote ceftobiprole 44 Accelrys Symyx 44 risks anduncertainties 44 Offerors Commercial applies 44 NewAlliance stockholders 44 bookrunning managers 44 Stalking Horse Bid 44 Axtive 44 prospectus supplement relating 44 MZT Holdings 44 supplements thereto 44 applicable indentures 44 Each Subscription Receipt 44 Definitive Agreements 44 Resulting Issuer Shares 44 Seek Shareholder Approval 44 broker warrants exercisable 44 Facet Biotech stockholders 44 reorganized WMI 44 Friendly LRL 44 Special Stockholder Meeting 44 Short Explanation 44 Convertible Subordinated Notes 44 Montaur 44 convertible subordinated debentures 44 voluntarily deregister 44 Resale Registration Statement 44 Exchangeco 44 Triggering Event 44 Nasdaq Deficiency Notice 44 Contingent Value Right 44 NQCI 44 Maple Merger Sub 44 Schedule #A filed 44 Permitted Bid provisions 44 Purchase Agreement 44 Restricted Share 44 convertible subordinated 44 Convertible Senior 44 Pharmagesic 44 NASDAQ IMDC 44 debentureholders 44 AcquisitionCo 44 Merger Transactions 44 Compensation Warrants 44 mandatorily convert 44 Shareholders Overwhelmingly Approve 44 Millstream II 44 Announces Reverse Split 44 prospectus relating 44 Symyx stockholders 44 NitroMed BiDil 44 Nasdaq WCRX 44 approvals 44 Qinnan PSC 44 Offeror 44 Medigen 44 Shares Plunged What 44 MR Civ 44 Qualifying Transaction pursuant 44 vinorelbine emulsion 44 supplemental indenture containing 44 Unitholder Rights 44 optionholder 44 Corporation NASDAQ BKCC 44 Special Shareholder Meeting 44 cornered amalgamation 44 Adopts Shareholder Rights 44 CoSine 44 SmallCap Market 44 visit www.regenbio.com 44 Orthodontix 44 MarkWest Hydrocarbon 44 Nasdaq LTXC 44 Merger dated 44 Receives Notice Regarding 44 Signs Binding Agreement 44 AXA APH minority 44 Pamrapo Bancorp 44 Refinancing Transactions 44 Debt Settlement Agreements 44 Airesurf 44 #,#,# ADSs [001] 44 Nasdaq Listing Rules 44 convertible debenture financing 44 Nasdaq EPCT 44 Recommendation Statement 44 STSPL 44 noncumulative perpetual preferred 44 Scheme Effective Date 44 Bluehill ID 44 MURRIETA CA #/#/# 44 MBMI Closes 44 indenture amendments 44 addition AGC AVK 44 Underwriting Agreement 44 securities issuable pursuant 44 Receives Notification 44 Bylaw amendments 44 disinterested Shareholder approval 44 Novoste 44 Shareholders Approve Merger Agreement 44 dilutive 44 Notification Related 44 Arana Therapeutics Limited 44 Indentures 44 Frontino Acquisition 44 noteholder 44 Top Favour 44 Pending Merger 44 accreted principal 44 NMH Holdings 44 Pre QT Financing 44 Related Parties 44 Subscription Receipts 44 Subordinate Voting Shares 44 Koosharem Corporation 44 ANR.U 44 acquire Medafor 44 Completes Second Tranche 43 auditor attestation 43 HFF Holdings 43 Wolf Haldenstein Investigating 43 LitFunding 43 Nasdaq Listing Qualification 43 CMI Entities 43 hereof shall 43 Non Brokered Offering 43 Acceptance Date 43 GSR Bid 43 Miscellaneous Fares 43 QuaTech 43 Adjournment Proposal 43 Listing Qualifications Staff 43 merging Rozetta Cell 43 Amalgamation Resolution 43 NNL preferred 43 Mago ® 43 shareholders optionholders 43 Dobhai 43 ReNvision 43 Rhein Biotech NV 43 Inc. Nasdaq CRTX 43 Georox Resources Inc. 43 Definitive Agreement whereby 43 prepackaged Chapter 43 SouthWest Water stockholders 43 Announces Delisting 43 Liquidation Proposal 43 Terminate Merger Agreement 43 proration procedures 43 Inc. Nasdaq ZILA 43 Secured Debentures 43 NYSE Amex 43 Recommends Shareholders Vote 43 successfully commercialize Silenor 43 PRRF 43 redomiciliation 43 MCTO 43 Regains Full 43 documentation evidencing 43 convertible debentures 43 Completes Merger With 43 SyntheMed 43 Indenture 43 Offer Period 43 NASDAQ CYBS 43 Restated Declaration 43 USEB Chapter 43 Shareholder Vote 43 Fancamp Announces 43 theSecurities 43 Nasdaq CYCC Nasdaq CYCCP 43 Offeree 43 Shelf Registration Statement 43 Proxy Circular 43 Graphic Packaging Corporation 43 Proposed Takeover 43 Definitive Merger Agreement 43 Recapitalisation Proposal 43 ticker LUPE 43 underwriting discounts commissions 43 Employment Inducement Award 43 MagHoldings Shares 43 Receives Shareholder Approval 43 NASDAQ MOGN 43 Exchangeable Shares 43 WDEQ Permit 43 SI Bancorp MHC 43 CEFF financings subject 43 Extends Tender Offer 43 underwriters overallotment option 43 Praecis 43 Prime Securityholders 43 Consent Revocation Statement 43 Expiration Date 43 Shareholder Rights 43 Inc. Nasdaq NSIT 43 immediately separable 43 Amends Tender Offer 43 Investigates Breach 43 Inc. Nasdaq TRMA 43 Qualifying Transaction QT 43 Written Consent 43 subscription receipts 43 Confirms Receipt 43 TriPath Oncology 43 Senior Convertible Notes 43 Consent Time 43 Adjourns Annual Meeting 43 Annual Incentive Plan 43 Receives Delisting Notice 43 FSAH 43 Fampridine SR Acorda Therapeutics 43 convertible noteholders 43 Minsud 43 ticker symbol UAUA 43 Tikcro 43 Leezamax 43 Convertible Senior Subordinated 43 Minimum Condition 43 symbol TSH 43 Restructures Debt 43 Announces Revocation 43 Announces Consummation 43 Acquireco 43 prospectus proxy 43 Merger 43 Arcion Therapeutics 43 specify Kirrin News 43 Company TSX.V HLS 43 Paivis Corp. PINKSHEETS PAVC 43 NASDAQ Minimum Bid 43 Escrowed Shares 43 Inc. Nasdaq CVTX 43 secured promissory note 43 NNL preferred shareholders 43 Xphase 43 NASDAQ Deficiency Notice 43 DIP Loan 43 LCE Holdings 43 Shareholders Approve Proposed 43 Proposed Disposition 43 ZTEST Announces 43 ZIGO 43 HSR Antitrust Improvements 43 #D filing 43 repurchase authorizations 43 Preferred Shares 43 Deregister 43 Staff Deficiency Letter 43 AllianceBernstein Holding Units 43 Completes Tender Offer 43 Angiotech Entities 43 Otix 43 ASTC Settlement Rules 43 BlackRock Kelso 43 NASDAQ LBTYK 43 Solectron stockholders 43 BostonGen 43 Amex VTG NYSE Amex 43 MethyPatch 43 file Form #b 43 beneficially owned 43 Amended Merger Agreement 43 Accelerated Share Repurchase 43 definitive Joint Proxy 43 Early Settlement Date 43 LTX Credence 43 Closes Non Brokered 43 Elitech 43 Nasdaq GNLB 43 proprietary Capillary Aerosolization Technology 43 VBV LLC 43 OFCD Optionally Fully 43 NASDAQ GNTA 43 ECMV 43 please visit www.cpexpharm.com 43 Underwriters Exercise 43 Novoste Corporation 43 WSE IVX 43 NM SYMBOL ORBK 43 Criticare stockholders 43 CFO Exercises Options 43 Thinkorswim shareholders 43 Specifications pricing 43 injunction enjoining 43 AENY common 43 hereby notifies 43 WHITE proxy 43 indenture governing 43 BacTech Environmental 43 Rule #b 43 maximize stockholder 43 Simo Holdings 43 proxystatement 43 CreXus Investment Corp. 43 SFOD Offering 43 VenGrowth Funds 43 Announces Share Repurchase 43 Nasdaq OFIX 43 SIFT Rules 43 Cytopia shareholders 43 voluntary delisting 43 Warrant Expiry Date 43 Cumulative Perpetual Preferred Stock 43 Celeritek 43 MOU contemplates 43 Restated Agreement 43 Offeror intends 43 Reverse Split Proposal 43 Successfully Completes Tender Offer 43 Note Movie showtimes 43 Definitive Proxy Statement Prospectus 43 CVRs 43 NASDAQ DNBK 42 NYSE PHH PHH 42 Platinum Merger Sub 42 AMICAS stockholders 42 Omnibus Incentive Compensation 42 CapGen 42 Supplemental Indenture 42 #,#,# Subscription Receipts [002] 42 Tender Offer Memorandum 42 MedCom USA Inc. 42 Amended Option Agreement 42 Convertible Debentures 42 Cobalis Corp 42 WorldSage 42 Primedex 42 NASDAQ TARG 42 aggregate principal 42 Expiration Time 42 Revised Recommended 42 Airgas Annual Meeting 42 Inc. OTCBB VIVK 42 Componus 42 Firm Recommends 42 Statement #R 42 Stockholder Vote 42 Edgen Corporation 42 Vitol Anker 42 NASDAQ XETA 42 Nasdaq Notice Regarding 42 MedEmerg 42 Securityholders Approve 42 Rejects Unsolicited 42 Nasdaq PPCO 42 SMTEK 42 Incentive Warrants 42 please visit www.middlebrookpharma.com 42 Tender Offer Statement 42 Flow Through Offering 42 Annual Meeting Date 42 Valera Pharmaceuticals Inc. 42 Pharmacopeia Phase 42 Equity Inducement 42 NanoSensors 42 NASDAQ CLZR 42 Consent Expiration Date 42 Consent Solicitation 42 AMEX AOM 42 Zanaflex Capsules competition 42 Default Notice 42 RWCI 42 ADVENTRX 42 integrating ADVO operations 42 Stockholder Protection 42 Form #F 42 symbol HAWK 42 HNTE 42 Epimmune 42 dedicated CHAT ROOM 42 ii 42 netGuru 42 Inc. Nasdaq PHMD 42 Nasdaq CCBP 42 unsubscribed shares 42 Common Stock Repurchase 42 Notes Indenture 42 senior subordinated notes 42 Delavaco Energy 42 Remain Listed 42 Subco 42 Required Documents 42 Conditions Precedent 42 COMFORCE 42 TorreyPines Therapeutics 42 Delisting Notice 42 KPE unitholders 42 Nasdaq MGRM 42 Adjourns Special Meeting 42 Signs Merger Agreement 42 Northwest Bancorp MHC 42 Cardiogenesis Corporation 42 ticker symbol CNVR 42 Brokered Offering 42 CORLUX CORT # 42 Grandfathered Person 42 Files Annual Report 42 Explanatory Statement accompanying 42 BCY 42 Geosam 42 DIP Financing 42 BioStem Inc. 42 Form 8K 42 Delned 42 Existing Debentures 42 SEC Form #F 42 Recapitalization Plan 42 LYONs 42 Shareholders Approve Acquisition 42 Occam Networks stockholders 42 Dividend Date 42 Biologic License Application BLA 42 Stockwire.com CHAT LIVE 42 indentures governing 42 Warburg Pincus Private Equity 42 exhibits thereto 42 JHP Pharmaceuticals LLC 42 indebtedness incurred 42 Subsidiary Guarantors 42 TargetCo 42 Completes Debt Refinancing 42 Taglich Brothers Initiates Coverage 42 NOVT 42 Optionees 42 NASDAQ TGEN 42 PVG unitholders 42 Proprius Pharmaceuticals 42 Files Registration Statement 42 issuable upon 42 Brokered Placement 42 leveraged recapitalization 42 exchangeable shares 42 HNW trades 42 Joint Proxy 42 Sipex stockholders 42 Share Incentive Plan 42 Completes Reorganization 42 Exploring Strategic Alternatives 42 Voting Convertible Preferred 42 holder thereof 42 BostonFed 42 CCU Notes 42 repurchased 42 NASDAQ ABPI 42 ePAK 42 Inc. Nasdaq SLXA 42 Nasdaq WATG 42 OCTI 42 Rocmec Closes 42 Annual Stockholders 42 Candela Corporation 42 Stelmar shareholders 42 Announces Stock Repurchase 42 amendments thereto 42 Valera Pharmaceuticals 42 - Stockholders equity [009] 42 Avaranta 42 Nasdaq CLZR 42 Neurogen disclaims 42 Increases Share Repurchase 42 Restructured Canwest 42 Perlite Canada inc 42 Debentures tendered 42 Compulsory Acquisition 42 Dycom Investments 42 Business Corporations Act